TMO: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/982cee2a-8005-4ab9-bb71-324971d44fcb/","filing_uuid":"982cee2a-8005-4ab9-bb71-324971d44fcb","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/982cee2a-8005-4ab9-bb71-324971d44fcb/print/","filing_document_content_type":"text/html","income":"21000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John Kevin Brennan","dt_posted":"2026-10-16T16:06:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4620 Van Ness St, NW","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20016","registrant":{"id":401105447,"url":"https://lda.gov/api/v1/registrants/401105447/","house_registrant_id":null,"name":"BLUEBIRD STRATEGIES","description":"Consulting firm.","address_1":"4620 Van Ness St, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20016","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN KEVIN BRENNAN","contact_telephone":"+1 202-253-0924","dt_updated":"2026-07-07T11:45:17.907337-04:00"},"client":{"id":203728,"url":"https://lda.gov/api/v1/clients/203728/","client_id":48,"name":"THERMO FISHER SCIENTIFIC INC","general_description":"Scientific product and technology company.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-11-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72006,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KEVIN","last_name":"BRENNAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}